You are here: Industry Insights > Financing

News List

Development Progress of Bispecific Antibodies in China Yefenghong/PharmaSources
November 07, 2023
Approved Bispecific Antibody Products Worldwide, New progress in the field of bispecific antibodies.
Pharmaceutical Business in China and Worldwide (September)(2023) PharmaSources
October 01, 2023
Pharmaceutical companies reached a cooperation agreement and began to commercialize drugs for the treatment of diseases.
Supported by Capital, the Application of mRNA Technology has Become a Hot Field in China PharmaSources/Xiaoyaowan
December 17, 2021
In the middle of August, Abogen Biosciences announced that it had completed a third round of financing with its total amount exceeding 700 million US dollars, which set a new record for single financing before IPO of Chinese biopharmaceutical companies.
ANTABIO Raises €25 Million in Series B Financing B3C newswire
December 13, 2023
Antabio SAS announced today that it has raised €25m in a series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from the company’s historical investors including BNP Paribas Développement.
Huma raises $130 million financing to scale its digital health platform for better care and research expresspharma
May 13, 2021
Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance care and research.
Wren Therapeutics raises £12.4m in latest financing round pharmatimes
January 27, 2021
Cambridge, UK-based biopharmaceutical company Wren Therapeutics has completed the closing of £12.4m financing, taking its total capital raised to date to around £33m.
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies prnasia
January 08, 2021
Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, announced the first closing of an oversubscribed $53.5 million Series B+ financing.
DXY completes USD 500 million financing, to enhance its professional role in healthcare sector prnasia
December 30, 2020
On December 28, DXY, a leading digital healthcare technology company in China, announced the completion of a USD 500 million financing.
AIVITA Biomedical Closes $25 Million Financing Round prnewswire
December 30, 2020
AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, has closed its Series B-2 financing round for up to $25 million. Financing was provided by several life ...
Foresee Pharmaceuticals Announces Completion of US$47 Million Financing prnasia
December 25, 2020
Foresee pharmaceuticals announces that it has successfully completed an underwritten public offering of 15,000,000 shares of its common stock to the public at a price of NT$88 per share.

Previous page 1 2 3 4 5 6 7 Next page